1979•PubMedOpen access

A randomized controlled trial of aspirin in the prevention of early mortality in myocardial infarction.

P C Elwood, WT Williams

Abstract

A randomized controlled trial is reported in which a single dose of aspirin (300 mg) was given to patients with myocardial infarction on first contact with a general practitioner. A total of 1,705 patients with confirmed infarction were studied, and survival ascertained. There was no evidence of benefit from the aspirin.

About this research paper

What this paper is about

Why it matters

OpenAlex reports 52 citations for this work. Citation counts describe recorded attention and do not establish research quality.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

Key concepts: Aspirin, Myocardial infarction, Randomized controlled trial, Medicine, Internal medicine, Infarction, Cardiology